The aryl hydrocarbon receptor (AHR) recognizes xenobiotics as well as natural compounds such as tryptophan metabolites, dietary components and microbiota-derived factors 1-4 , and it is important for maintenance of homeostasis at mucosal surfaces. AHR activation induces cytochrome P4501 (CYP1) enzymes, which oxygenate AHR ligands, leading to their metabolic clearance and detoxification 5 . Thus, CYP1 enzymes have an important feedback role that curtails the duration of AHR signalling 6 , but it remains unclear whether they also regulate AHR ligand availability in vivo. Here we show that dysregulated expression of Cyp1a1 in mice depletes the reservoir of natural AHR ligands, generating a quasi AHR-deficient state.
The aryl hydrocarbon receptor (AHR) recognizes xenobiotics as well as natural compounds such as tryptophan metabolites, dietary components and microbiota-derived factors [1] [2] [3] [4] , and it is important for maintenance of homeostasis at mucosal surfaces. AHR activation induces cytochrome P4501 (CYP1) enzymes, which oxygenate AHR ligands, leading to their metabolic clearance and detoxification 5 . Thus, CYP1 enzymes have an important feedback role that curtails the duration of AHR signalling 6 
, but it remains unclear whether they also regulate AHR ligand availability in vivo. Here we show that dysregulated expression of Cyp1a1 in mice depletes the reservoir of natural AHR ligands, generating a quasi AHR-deficient state. Constitutive expression of Cyp1a1 throughout the body or restricted specifically to intestinal epithelial cells resulted in loss of AHR-dependent type 3 innate lymphoid cells and T helper 17 cells and increased susceptibility to enteric infection. The deleterious effects of excessive AHR ligand degradation on intestinal immune functions could be counter-balanced by increasing the intake of AHR ligands in the diet. Thus, our data indicate that intestinal epithelial cells serve as gatekeepers for the supply of AHR ligands to the host and emphasize the importance of feedback control in modulating AHR pathway activation.
It is increasingly understood that AHR signalling needs to be tightly controlled, as prolonged activation either by ligands that resist metabolic clearance or by constitutively active AHR has deleterious effects [7] [8] [9] [10] . Enzymes of the CYP1A and CYP1B sub-families (CYP1) control AHR signalling owing to their capacity for metabolizing ligands and thereby terminating AHR activation.
We hypothesized that excessive CYP1A1-mediated metabolic clearance of natural AHR ligands would affect the intestinal immune system, in which several immune cell types are dependent on AHR signalling for their survival. To investigate this, we generated a mouse model with constitutive Cyp1a1 expression owing to its placement under control of the Rosa26 promoter (mice denoted hereafter as R26 Cyp1a1 ) (Extended Data Fig. 1 ). As proof of principle, we investigated the effect of constitutive Cyp1a1 expression on T helper 17 (T H 17) cells, which express AHR and produce interleukin 22 in an AHR-dependent manner 11 . T H 17 cells generated from R26 Cyp1a1 mice had increased CYP1A1 enzymatic activity compared with wildtype B6 or Ahr-deficient T H 17 cells (Fig. 1a ). To assess metabolic clearance of AHR ligands, CD4 + T cells from wild-type, Ahr-deficient or R26 Cyp1a1 mice were cultured under T H 17-cell-inducing conditions in the presence of the endogenous, tryptophan-derived AHR ligand 6-formylindolo [3,2-b] )carbazole (FICZ) and residual cellular FICZ levels determined at various time points. FICZ did not decay in cultures of Ahr-deficient T H 17 cells owing to the absence of CYP1A1 induction, but cultures of R26 Cyp1a1 T H 17 cells showed accelerated clearance of FICZ compared with those from wild-type T H 17 cells (Fig. 1b ). Furthermore, T H 17 cells generated from R26 Cyp1a1 mice produced less IL-22 in response to baseline AHR ligands present in culture medium 12 and to low, but not higher, FICZ concentrations ( Fig. 1c , Extended Data Fig. 2 ). Ahr-deficient T H 17 cells did not produce IL-22 under any condition (Fig. 1c ). Thus, constitutive CYP1A1 activity decreased AHR ligands and compromised IL-22 production.
Ahr deficiency in haematopoietic cells causes the disappearance of intraepithelial lymphocytes 13 and type 3 innate lymphoid cells (ILC3) in the intestinal immune system [14] [15] [16] . R26 Cyp1a1 mice exhibited enhanced intestinal CYP1A1 enzyme activity (Extended Data Fig. 3a ) and loss of ILC3 in colon and small intestine similar to Ahr-deficient mice ( Fig. 1d , e, Extended Data Fig. 3b ), suggesting that continuous metabolic clearance of natural AHR ligands mimics an Ahr-deficient state. In addition, R26 Cyp1a1 mice displayed similar developmental abnormalities to Ahr-deficient mice, such as decreased liver weight indicative of patent ductus venosus 17 (Extended Data Fig. 4 ).
We next investigated the response of R26 Cyp1a1 mice to infection with the intestinal pathogen Citrobacter rodentium, which causes severe pathology in Ahr-deficient [14] [15] [16] , compared with wild-type mice. R26 Cyp1a1 mice also had increased pathology, albeit not as extensive as that seen in Ahr-deficient mice ( Fig. 2a,b ). Whereas all wild-type mice survived the infection, Ahr-deficient mice reached end-point by day 9 after infection and R26 Cyp1a1 mice survived only a few days longer ( Fig. 2c ). C. rodentium penetrated deeply into the base of the crypts in Ahr-deficient and R26 Cyp1a1 mice, but mainly attached to the luminal surface of the epithelium in wild-type mice (Fig. 2d ). The bacterial burden in the colon of Ahr-deficient and R26 Cyp1a1 mice was higher and failure to clear the infection resulted in dissemination of bacteria to liver and spleen ( Fig. 2e ). IL-22 is essential in the defence against C. rodentium 18 and the marked susceptibility of Ahr-deficient mice can be attributed to their lack of ILC3 as well as failure to mount a T H 17cell IL-22 response. This deficiency in IL-22 as well as T H 17 cells and ILC3 was mirrored in R26 Cyp1a1 mice ( Fig. 2f , g). Administration of recombinant IL-22-Fc fusion protein significantly reduced bacterial burden and crypt invasion and prolonged the survival of R26 Cyp1a1 mice (Extended Data Fig. 5 ). Thus, constitutive Cyp1a1 expression severely impairs the intestinal immune response against an enteric pathogen.
Given that CYP1A1-mediated clearance of natural ligands produces a quasi Ahr-deficient state, the absence of metabolic clearance should increase ligand availability. To test this, we investigated mice with deletion of the three AHR-controlled CYP enzymes CYP1A1, CYP1A2 and CYP1B1, termed Cyp1-knockout mice 19 . T H 17 cells from Cyp1-knockout mice failed to metabolize FICZ and showed increased Cyp1a1 expression and enhanced IL-22 production in the absence of added AHR ligands as well as reduced histopathology scores and bacterial burdens upon infection (Extended Data Fig. 6 ).
Increased ligand availability in Cyp1-deficient mice was visualized in a Cyp1a1 fate-reporter strain that reports AHR activity through induction of an enhanced yellow fluorescent protein (eYFP) reporter activated through targeted insertion of Cre recombinase in the mouse Cyp1a1 locus 20 . Although Cyp1-deficient mice failed to produce this enzyme, they still reported AHR stimulation with induction of Cre-mediated eYFP expression. In the intestine of wild-type Cyp1a1 reporter mice, eYFP expression was scarce, which reflected the transient nature of AHR signalling that limits Cre induction ( Fig. 3a , left). However, Cyp1-deficient mice showed enhanced eYFP expression primarily in EpCAM + intestinal epithelial cells (IECs) ( Fig. 3a left). Dietary supplementation with indole-3-carbinol (I3C), a tryptophan-derived phytochemical that is converted to high-affinity AHR ligands by exposure to stomach acid 21 , further enhanced the eYFP signal in EpCAM + IECs of Cyp1-deficient mice ( Fig. 3a, b ).
It has been shown previously that IEC-specific deletion of the AHR partner ARNT (AHR nuclear translocator) causes systemic upregulation of Cyp1a1 (ref. 22) . Thus, we next tested Vil1-cre-R26 LSL-Cyp1a1 mice (termed IEC Cyp1a1 ), in which Cyp1a1 expression was restricted to IECs (Extended Data Fig. 1b ). Notably, IEC Cyp1a1 mice had markedly reduced numbers of ILC3, similar to Ahr-deficient mice and mice with constitutive Cyp1a1 expression throughout the body (Fig. 3c ). In contrast, mice with constitutive Cyp1a1 expression restricted to adaptive immune cells through Rag1-cre (Rag1 Cyp1a1 ), had normal numbers of ILC3 under steady state conditions ( Fig. 3c , Extended Data Fig. 1b ). This suggests that constitutive CYP1A1 activity in IECs, but not in adaptive immune cells, restricts the availability of AHR ligands to cells in the intestinal lamina propria, resulting in loss of AHR ligand-dependent ILC3.
Upon infection with C. rodentium, IEC Cyp1a1 mice rapidly succumbed ( Fig. 3d ), with increased bacterial crypt invasion ( Fig. 3e ) and intestinal pathology ( Fig. 3f ). C. rodentium disseminated into the liver and spleen of IEC Cyp1a1 mice (Fig. 3g ), and the reduction of ILC3 and T H 17 cells collectively affected the level of IL-22 that was detectable in colon tissue ( Fig. 3h ). In contrast, Rag1 Cyp1a1 mice infected with C. rodentium had survival rates similar to wild-type mice over 14 days after infection and had no significant differences in bacterial load, pathology score or dissemination of bacteria (Extended Data Fig. 7a -c). Whereas ILC3 were not affected, T H 17 cells and their IL-22 production were strongly reduced (Extended Data Fig. 7d ). Thus, enhanced AHR ligand degradation in T cells compromises T-cell-derived IL-22 responses, but spares ILC3. In contrast, enhanced AHR ligand degradation in IECs deprives ILC3 as well as T cells of AHR stimulation, thereby causing a more severe deficiency in immune defence against C. rodentium.
We next investigated whether lack of AHR ligand metabolism in non-haematopoietic cells affects the immune response to C. rodentium infection. We generated bone marrow chimaeras by transferring wildtype donor bone marrow into irradiated wild-type (WT→ WT) or Cyp1-deficient (WT→ Cyp1 −/− ) recipients, followed by infection with C. rodentium. WT→ Cyp1 −/− chimaeras showed significantly reduced pathology ( Fig. 3i ), as well as bacterial loads ( Fig. 3j ), compared with wild-type recipients (WT→ WT). Furthermore, Cyp1 −/− recipients had increased numbers of wild-type donor-derived ILC3 and T H 17 cells and markedly higher IL-22 levels ( Fig. 3k ). Thus, absence of CYP1-mediated AHR ligand metabolism in IECs results in increased ligand availability to intestinal immune cells and promotes resistance to enteric infection. These data are consistent with a crucial role for IECs as gatekeepers for the availability of AHR ligands in the intestinal immune system.
To further substantiate the role of CYP1A1 in controlling ligand availability, we investigated whether increasing AHR ligands by adminis tration of I3C in the diet might mitigate the loss of AHR signalling in R26 Cyp1a1 mice. R26 Cyp1a1 mice that were fed on control diet and infected with C. rodentium succumbed to infection, whereas mice on the I3C-supplemented diet survived and had cleared the infection by day 14 (Fig. 4a, b) . Penetration of C. rodentium to the crypts was abrogated ( Fig. 4c ) and mice on the I3C diet had markedly Letter reSeArCH reduced pathology ( Fig. 4d, e ). In R26 Cyp1a1 mice on the I3C diet, IL-22producing cells were able to recover ( Fig. 4f, g) , whereas blockade of IL-22 abrogated the protective effect of I3C diet administration (Fig. 4h ). The beneficial effect of I3C is due to the combination of strong inhibition of CYP1A1 activity by its acid-condensation products DIM and ICZ ( Fig. 4i ) and the agonist activity of DIM and ICZ, which are known AHR ligands 23 . ICZ, like FICZ but unlike DIM, is also efficiently metabolized by CYP1A1 (Extended Data Fig. 8 ). Thus, the excessive clearance of natural ligands, which produces a quasi Ahr-deficient state in R26 Cyp1a1 mice, can be ameliorated by the supply of dietary AHR ligands, allowing sufficient AHR signalling to restore IL-22 production by T H 17 cells and successful eradication of C. rodentium.
The AHR pathway is of crucial importance in the intestinal immune system and genome-wide association studies have identified AHR as a susceptibility locus in inflammatory bowel disease 24 . Although the main focus has been on AHR itself or on its ligands 2,4,25 , we show here that feedback regulation of the AHR pathway by CYP1 enzymes controls ligand availability and thereby activation of the AHR pathway, with a critical role for IECs in controlling availability of ligands to the intestinal immune system. Thus, constitutive CYP1A1 activity in IECs reduced the availability of AHR ligands in the body, causing the decay of intestinal immune cells, such as ILC3, that depend on AHR signals for survival and impairment of the adaptive IL-22 response upon infection with intestinal pathogens. Conversely, lack of CYP1A1mediated metabolism confined to IECs had the opposite effect, increasing protection against intestinal infection.
As previously shown in an in vitro setting, inhibition of CYP1A1 results in a boost to AHR pathway activation owing to increased availability of the AHR ligand FICZ 26 . Here we demonstrate that genetic deletion of CYP1 enzymes delays ligand metabolism, resulting in increased AHR signals in vivo. Sources of AHR ligands are abundant and include dietary compounds 21 , microbial virulence factors 4 and AHR ligands derived through microbiota-or host-cell-mediated tryptophan metabolism 2 . Given that environmental factors such as oxidative stress, chemical pollutants and dietary components modulate CYP1 enzyme activity 26 , interference with CYP1-mediated AHR ligand degradation has potential consequences for AHR pathway activation and intestinal homeostasis. Our finding that the intestinal pathology resulting from constitutive CYP1A1 activity could be counter-balanced by increasing the intake of AHR ligands in the diet suggests that dysregulated CYP1A1 is potentially amenable to therapeutic manipulation through dietary supplementation.
Letter reSeArCH (all eBioscience) and RORγ t (BD Biosciences). Cells were acquired with a BD Fortessa X20 and analysis was performed with FlowJo v10 (Tree Star) software. HPLC analysis of FICZ clearance. CD4 + T cells were isolated and cultured under T H 17-cell-inducing conditions as described above and 5 nM FICZ (EnzoLifeSciences) added at the start of culture. At various time-points, cells were collected, washed in PBS and re-suspended in 200 μ l distilled water and stored at − 20 °C. Before high performance liquid chromatography (HPLC) analysis, the cells were homogenized by sonication on ice (4 × 5 s) using a MSE Soniprep 150 equipped with an exponential probe (Measuring and Scientific Equipment). Extraction and chemical analysis of the homogenates, using an in-line solid-phase extraction column coupled to a reverse-phase C18 analytical column, was performed as previously described 26 . FICZ quantity was determined according to a standard curve of FICZ and the results were normalized to total protein contents determined by Pierce Coomassie protein assay kit according to the manufacturer's instructions. CYP1A1-mediated metabolism of DIM, ICZ and FICZ. Time-dependent metabolism of DIM, ICZ and FICZ was studied in the presence of human recombinant CYP1A1 (3.5 nM) and the co-factor NADPH (1.0 mM). Each compound (0.1 μ M) was incubated with CYP1A1 and NADPH in Tris-HCl (0.1 M, pH 7.4) with EDTA (1 mM) at 37 °C. At various time-points, samples were collected and acetonitrile was added to each sample at a final concentration of 20%, followed by vortexing (30 s) and centrifugation (10 min at 12 × 10 6 r.p.m. and 4 °C). Chemical analysis of the supernatants was performed using the same HPLC equipment as for the cellular clearance measurements. Separation of respective compound was achieved using a reverse-phase C18-AR column (ACE, 4.6 × 150 mm, 5 μ m particle size) with a mobile phase consisting of water (A) and acetonitrile (B), both containing 1.5 mM formic acid. Initially, the solvent contained 30% B, with a linear increase to 100% B during a period of 20 min, at a flow rate of 0.8 ml min −1 . DIM, ICZ and FICZ was detected using excitation/emission wavelengths of 230/460 (DIM and ICZ) or 390/525 nm (FICZ). All compounds were quantified according to separate standard curves. To determine non-enzymatic degradation of each compound parallel incubations were performed where phosphate buffer was substituted for NADPH.
Ethoxyresorufin-O-deethylase (EROD) assay.
Intestinal tissue homogenates or CD4 + T cells cultured for 48 h under T H 17-cell-inducing conditions were washed in PBS followed by incubation with 2 μ M 7-ethoxyresorufin in sodium phosphate buffer (50 mM, pH 8.0) at 37 °C for 30 min. The reaction was terminated by adding fluorescamine (Sigma) dissolved in acetonitrile. Formation of resorufin (excitation/ emission of 535/590 nm) and fluorescamine (excitation/emission of 390/485 nm) was quantified using a plate reader. Inhibition of CYP1A1 activity by I3C, DIM and ICZ. Effects on the EROD activity of human recombinant CYP1A1 (2.5 nM) was assayed by first preincubating the enzyme with the compound to be tested for 5 min in Tris-HCl (0.1 M, pH 7.4) with EDTA (1 mM) at 37 °C followed by addition of ethoxyresorufin (0.1 μ M) and NADPH (0.4 mM). Formation of resorufin was quantified using a multiwell plate reader (with the excitation/emission wavelengths of 535/590 nm) and activity of the enzyme was determined by the rate of resorufin formation. ICZ and FICZ were purchased from Syntastic AB. DIM, I3C, 7-ethoxyresorufin, β -Nicotinamide adenine dinucleotide 2′ -phosphate (NADPH, N7505) and human recombinant cytochrome P4501A1 with P450 reductase (C3735) was purchased from Sigma-Aldrich. Immunofluorescence microscopy. Tissues were fixed in 4% phosphate-buffered formaldehyde solution (Fisher Scientific) for 24 h. Fixed tissue sections were de-paraffinized and antigen retrieval performed in 0.01 M sodium citrate buffer. Slides were blocked with goat serum, stained with mouse anti-E-cadherin (BD, 610181) and rabbit anti-C. rodentium antiserum, followed by staining with secondary antibodies (AF555-conjugated goat anti-rabbit and AF488-conjugated goat anti-mouse from ThermoFisher). Slides were further stained with DAPI (Sigma) and mounted in Fluoromount-G (SouthernBiotech) and visualized using a Leica Confocal SP5-Invert microscope. For staining of eYFP, tissue sections were fixed in 4% paraformaldehyde at 4 °C for 16 h followed by incubation in 30% sucrose for 24 h. Tissues were embedded in OCT compound (VWR) followed by cryosectioning. Slides were blocked with rabbit serum and stained with AF488conjugated rabbit anti-GFP (ThermoFisher, A21311) and AF647-conjugated mouse anti-E-cadherin (BD, 560062) and visualized using a Leica Confocal SP5-Invert microscope. Image analysis was performed in ImageJ. Infection with Citrobacter rodentium. For C. rodentium infection, a single colony of strain DBS100 (ATCC 51459; American Type Culture Collection) was transferred to Luria-Bertani (LB) broth and grown to log phase, followed by centrifugation and resuspension in PBS. Mice were orally gavaged with 200 μ l of PBS containing 2 × 10 9 C. rodentium CFU. To determine bacterial load, intestinal tissue pieces or faecal pellets were weighed and homogenized in sterile PBS and
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Mice. For the generation of a constitutively active as well as an inducible Cyp1a1 allele the coding sequence (CDS) of Cyp1a1 was linked to the CDS of rat Thy1 using a 2A sequence. In order to stabilize the transcriptional activity of the inserted genes, a Woodchuck-hepatitis-virus-derived regulatory element in conjunction with a bovine growth hormone polyadenylation site was inserted 3′ end of the CDSs. This module was inserted downstream of a cassette containing an FRT-flanked neomycin-resistance gene and loxP-flanked transcriptional stop elements. The targeting vector did not contain any artificial promoter for the expression of both Cyp1a1 and rat Thy1 to avoid toxicity caused by CYP1A1 overexpression (details of the gene targeting and Rosa26-targeting strategy, Extended Data Fig. 1 ). The targeting vector was generated by Biocytogen and used to establish R26 Cyp1a1 -neoR mice by homologous recombination in BCGEN B61-6 (C57BL/6) embryonic stem cells. R26 Cyp1a1 -neoR mice were generated after successful germ-line transmission and backcrossed to C57BL/6J. This strain was further bred with mice expressing Cre recombinase under the control of the mouse protamine (Prm1) promoter to obtain constitutive Cyp1a1 expression in all cell types (referred to as R26 Cyp1a1 mice) or with ACTB-FLPe mice to obtain mice with a conditional floxed Cyp1a1 allele (referred to as R26 LSL-Cyp1a1 ). These were crossed with Vil1-cre mice to generate the IEC Cyp1a1 strain (constitutive Cyp1a1 expression specific to intestinal epithelial cells) and Rag1-cre mice to generate the Rag1 Cyp1a1 strain (constitutive Cyp1a1 expression specific to T and B cells).
To generate the Cyp1a1 reporter strain Cyp1a1-cre mice 20 (with targeted insertion of Cre recombinase in the mouse Cyp1a1 locus) were crossed with R26R-eYFP mice 27 , expressing eYFP from the ubiquitous Rosa26 promoter downstream of a cassette containing a loxP-flanked transcriptional stop element. This strain was further bred with Cyp1 −/− mice 19 to obtain Cyp1 −/− Cyp1a1 reporter mice. All mice used in this study were either generated in C57BL/6 embryonic stem cells or backcrossed to C57BL/6 mice for at least 10 generations. All mice were bred in the Francis Crick Institute animal facility under specified pathogen-free conditions. All animal procedures were conducted under a Project Licence granted by the UK Home Office. Mice were age-and sex-matched and more than 6 weeks old when first used. Both female and male mice were used in experiments. Generally, each mouse of the different experimental groups is reported. Exclusion criteria such as inadequate staining or low cell yield owing to technical problems were pre-determined. Animals were assigned randomly to experimental groups. In vitro T-cell differentiation. CD4 + T cells were isolated using EasySep mouse CD4 + T cell isolation kit (StemCell Technologies) with the addition of biotinylated anti-CD25 antibody (BioLegend). Cells were cultured in Iscove's modified Dulbecco medium (IMDM, Sigma) supplemented with 2 mM l-glutamine, 100 U ml −1 penicillin, 100 μ g ml −1 streptomycin, 0.05 mM β -mercaptoethanol and 5% fetal calf serum (biosera). CD4 + T cells were differentiated in 48-well plates coated with 1 μ g ml −1 anti-CD3 (clone 145-2C11, eBioscience) and 10 μ g ml −1 anti-CD28 (clone 37.51, BioLegend) in the presence of 2 ng ml −1 TGF-β 1, 20 ng ml −1 IL-6, 10 ng ml −1 IL-1β (all R&D Systems) and 10 μ g anti-IFN-γ (BioXCell). In some cultures, 6-formylindolo[3,2-b]carbazole (FICZ; EnzoLifeSciences) was added from the start of culture. IL-22 cytokine levels in culture supernatants were determined by ELISA assay (eBioscience).
Isolation of lamina propria cells and flow cytometry. Colon and small intestine
were cut open longitudinally and incubated in wash buffer (IMDM 1%FCS, 5 mM EDTA, 10 mM HEPES, penicillin/streptomycin, and 2 mM DTT) for 20 min at 37 °C with 200 r.p.m. shaking. Colon tissue was collected, cut into small pieces and incubated in digestion buffer (IMDM supplemented with 1% FCS, 10 mM HEPES, penicillin/streptomycin, 50 μ g ml −1 DNase I (Roche)) containing 0.4 mg ml −1 Liberase TL (Roche) and incubated for 30 min at 37 °C with 200 r.p.m. shaking. Small intestinal tissue was collected, cut into small pieces and incubated in digestion buffer (IMDM supplemented with 1% FCS, 10 mM HEPES, penicillin/ streptomycin, 50 μ g ml −1 DNase I (Roche)) containing 1 mg ml −1 collagenase VIII (Sigma) and incubated for 10 min at 37 °C with 200 r.p.m. shaking. Singlecell suspensions from colon and small intestine were further subjected to 40% Percoll (Amersham) density gradient centrifugation to remove debris. For surface staining, cell suspensions were incubated with anti-CD16/CD32 (eBioscience) and fixable live/dead cell dye (ThermoFisher) followed by staining with antibodies against CD11b, CD3, TCRγ δ , Gr1, CD11b, CD19, NKp46, CCR6, TCR-β , Thy1.1 (all BioLegend) and Thy1.2, CD45 and CD4 (all BD Biosciences). For intracellular staining, single-cell suspensions were re-stimulated for 2 h and 15 min in the presence of 1 ng ml −1 phorbol-12-myristate-13-acetate (PMA), 1 μ g ml −1 ionomycin and 10 μ g ml −1 Brefeldin A (all Sigma), washed and stained for surface markers as described above. Cells were then fixed in eBioscience Fix/Perm buffer or 4% formaldehyde (for preservation of eYFP fluorescence) for 30 min on ice followed by permeabilization in eBioscience permeabilization buffer for 45 min in the presence of antibodies against IL-17A, IL-22 and T-bet 
